1. Home
  2. FULT vs HAE Comparison

FULT vs HAE Comparison

Compare FULT & HAE Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo Fulton Financial Corporation

FULT

Fulton Financial Corporation

HOLD

Current Price

$19.59

Market Cap

3.5B

Sector

Finance

ML Signal

HOLD

Logo Haemonetics Corporation

HAE

Haemonetics Corporation

HOLD

Current Price

$83.09

Market Cap

3.9B

Sector

Health Care

ML Signal

HOLD

Company Overview

Basic Information
Metric
FULT
HAE
Founded
1882
1971
Country
United States
United States
Employees
N/A
3023
Industry
Major Banks
Medical/Dental Instruments
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
3.5B
3.9B
IPO Year
N/A
1991

Fundamental Metrics

Financial Performance
Metric
FULT
HAE
Price
$19.59
$83.09
Analyst Decision
Hold
Buy
Analyst Count
4
9
Target Price
$20.75
$88.38
AVG Volume (30 Days)
1.8M
671.6K
Earning Date
01-21-2026
02-05-2026
Dividend Yield
3.80%
N/A
EPS Growth
20.91
42.54
EPS
1.91
3.44
Revenue
$1,230,470,000.00
$1,327,850,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$15.37
$6.01
P/E Ratio
$10.45
$24.09
Revenue Growth
9.56
N/A
52 Week Low
$14.33
$47.32
52 Week High
$21.40
$87.32

Technical Indicators

Market Signals
Indicator
FULT
HAE
Relative Strength Index (RSI) 52.09 66.64
Support Level $19.09 $79.06
Resistance Level $20.08 $81.27
Average True Range (ATR) 0.37 1.55
MACD -0.11 -0.38
Stochastic Oscillator 30.06 88.74

Price Performance

Historical Comparison
FULT
HAE

About FULT Fulton Financial Corporation

Fulton Financial Corp is a U.S.-based financial services holding company that operates in five states: Pennsylvania, Delaware, Maryland, New Jersey and Virginia. It offers a range of consumer and commercial banking products and services, such as checking and savings deposit products and loan products. It offers consumer and commercial banking products and services, as well as wealth management products and services. The bank derives its revenue from non-interest income, led by its Wealth Management division.

About HAE Haemonetics Corporation

Haemonetics Corp aims to improve patient care and reduce the cost of healthcare by providing medical products and solutions in the blood and plasma component collection, surgical suite, and hospital transfusion service spaces. As such, the company operates under three segments: plasma, blood center, and hospital. The company primarily emphasizes its plasma and hospital segments due to their robust growth potential, whereas the blood center segment tends to be constrained by higher competition. Product revenue is driven by demand for disposable blood component collection and processing sets and the related equipment needed for proper functionality.

Share on Social Networks: